» Articles » PMID: 25541982

Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-associated Protein and is Required for Lipoprotein Passage

Overview
Journal PLoS One
Date 2014 Dec 27
PMID 25541982
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Liver sinusoidal endothelial cells (LSEC) are characterized by the presence of fenestrations that are not bridged by a diaphragm. The molecular mechanisms that control the formation of the fenestrations are largely unclear. Here we report that mice, which are deficient in plasmalemma vesicle-associated protein (PLVAP), develop a distinct phenotype that is caused by the lack of sinusoidal fenestrations. Fenestrations with a diaphragm were not observed in mouse LSEC at three weeks of age, but were present during embryonic life starting from embryonic day 12.5. PLVAP was expressed in LSEC of wild-type mice, but not in that of Plvap-deficient littermates. Plvap(-/-) LSEC showed a pronounced and highly significant reduction in the number of fenestrations, a finding, which was seen both by transmission and scanning electron microscopy. The lack of fenestrations was associated with an impaired passage of macromolecules such as FITC-dextran and quantum dot nanoparticles from the sinusoidal lumen into Disse's space. Plvap-deficient mice suffered from a pronounced hyperlipoproteinemia as evidenced by milky plasma and the presence of lipid granules that occluded kidney and liver capillaries. By NMR spectroscopy of plasma, the nature of hyperlipoproteinemia was identified as massive accumulation of chylomicron remnants. Plasma levels of low density lipoproteins (LDL) were also significantly increased as were those of cholesterol and triglycerides. In contrast, plasma levels of high density lipoproteins (HDL), albumin and total protein were reduced. At around three weeks of life, Plvap-deficient livers developed extensive multivesicular steatosis, steatohepatitis, and fibrosis. PLVAP is critically required for the formation of fenestrations in LSEC. Lack of fenestrations caused by PLVAP deficiency substantially impairs the passage of chylomicron remnants between liver sinusoids and hepatocytes, and finally leads to liver damage.

Citing Articles

Decoding liver fibrogenesis with single-cell technologies.

Zhou T, Kiran M, Lui K, Ding Q Life Med. 2025; 1(3):333-344.

PMID: 39872749 PMC: 11749458. DOI: 10.1093/lifemedi/lnac040.


Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells.

Wang L, Qu J, Li J, Xue X, Qin L, Li Y Chin Med. 2024; 19(1):179.

PMID: 39741334 PMC: 11686876. DOI: 10.1186/s13020-024-01038-1.


Early and late phases of liver sinusoidal endothelial cell (LSEC) defenestration in mouse model of systemic inflammation.

Czyzynska-Cichon I, Kotlinowski J, Blacharczyk O, Giergiel M, Szymanowski K, Metwally S Cell Mol Biol Lett. 2024; 29(1):139.

PMID: 39528938 PMC: 11556108. DOI: 10.1186/s11658-024-00655-w.


Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress.

Minetti E, Hamburg N, Matsui R Front Cardiovasc Med. 2024; 11:1469492.

PMID: 39411175 PMC: 11473390. DOI: 10.3389/fcvm.2024.1469492.


Semaphorin-3A regulates liver sinusoidal endothelial cell porosity and promotes hepatic steatosis.

Eberhard D, Balkenhol S, Koster A, Follert P, Upschulte E, Ostermann P Nat Cardiovasc Res. 2024; 3(6):734-753.

PMID: 39196233 PMC: 11358038. DOI: 10.1038/s44161-024-00487-z.


References
1.
Petersen A, Stark K, Musameh M, Nelson C, Romisch-Margl W, Kremer W . Genetic associations with lipoprotein subfractions provide information on their biological nature. Hum Mol Genet. 2011; 21(6):1433-43. DOI: 10.1093/hmg/ddr580. View

2.
Jacobs F, Van Craeyveld E, Feng Y, De Geest B . The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits. Cardiovasc Pathol. 2009; 20(1):44-50. DOI: 10.1016/j.carpath.2009.09.002. View

3.
Braet F, Spector I, de Zanger R, Wisse E . A novel structure involved in the formation of liver endothelial cell fenestrae revealed by using the actin inhibitor misakinolide. Proc Natl Acad Sci U S A. 1998; 95(23):13635-40. PMC: 24871. DOI: 10.1073/pnas.95.23.13635. View

4.
Herrnberger L, Ebner K, Junglas B, Tamm E . The role of plasmalemma vesicle-associated protein (PLVAP) in endothelial cells of Schlemm's canal and ocular capillaries. Exp Eye Res. 2012; 105:27-33. DOI: 10.1016/j.exer.2012.09.011. View

5.
Schuppan D, Kim Y . Evolving therapies for liver fibrosis. J Clin Invest. 2013; 123(5):1887-901. PMC: 3635731. DOI: 10.1172/JCI66028. View